GL1X · GenesisL1 explorer

Research workbench

Crystal structure of VEGFR2 (juxtamembrane and kinase domains) in complex with sorafenib (bay 43-9006)

Analyse Crystal structure of VEGFR2 (juxtamembrane and kinase domains) in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ASD
Type
protein
Length
305 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vascular endothelial growth factor receptor 2
EC
2.7.10.1
UniProt
P35968
Ligands
BAX
Pockets
1 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein30540% helix, 18% strandP35968

Ligands and binding sites

  • BAX · 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17060.750.8079BAX

Compared structures

  • 4ASD · Crystal Structure of VEGFR2 (Juxtamembrane and Kinase Domains) in Complex with SORAFENIB… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.